Steris agrees to buy Xodus Medical for $2.1 billion

By Public Technologies
  • Steris reached a definitive agreement to buy Xodus Medical, a Pennsylvania-based specialty surgical products maker, for USD 2.1 billion at closing.
  • Cash tax benefits with an estimated net present value of about USD 300 million imply a net purchase price of about USD 1.8 billion.
  • An earnout of up to USD 150 million is tied to specified post-closing performance targets in calendar 2028.
  • Xodus expects about USD 245 million of 2026 revenue, with adjusted EBIT of about USD 135 million.
  • Closing is targeted by Dec. 31, 2026; financing is expected to be primarily debt-funded.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Steris plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610120800PRIMZONEFULLFEED9843616) on October 12, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk